|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Clearing Regulatory Hurdles
Author(s)Christopher C. DeMerlis
The authors propose several models for independent evaluation of new excipients.
Advertisement
Articles in this issue
almost 22 years ago
FDA Will Drive Changes for Contract Businessalmost 22 years ago
In the Spotlight--Decemberalmost 22 years ago
Novemember 2003almost 22 years ago
FDA Seeks Risk-Based Inspection Programalmost 22 years ago
Routine Sample Size for a Retest Procedurealmost 22 years ago
November 2003almost 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
4
Best Practices for AI Adoption in Pharmaceutical Research
5
